Search research articles
Contact Us
Filters
Showing results (961-970 of 1,181) with videos related to
Page
of 119
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
The landscape of cancer rewired GPCR signaling axes
Chakit Arora, Marin Matic, Pierluigi DiChiaro, et al.
Plos One
|
February 25, 2022
Sample-to-answer, extraction-free, real-time RT-LAMP test for SARS-CoV-2 in nasopharyngeal, nasal, and saliva samples: Implications and use for surveillance testing
Kathryn A Kundrod, Mary E Natoli, Megan M Chang, et al.
Molecular Vision
|
March 13, 2018
Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment
Riccardo Natoli, Nilisha Fernando, Tess Dahlenburg, et al.
Journal of Clinical Medicine
|
April 23, 2022
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients
Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 7, 2012
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
Enza Piccolo, Nicola Tinari, Daniela Semeraro, et al.
Plos One
|
January 10, 2024
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
Chiara Ronchini, Chiara Caprioli, Gianleo Tunzi, et al.
Oncotarget
|
September 15, 2017
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial
Luca Moscetti, Maria Agnese Fabbri, Clara Natoli, et al.
Journal of Cancer Research and Clinical Oncology
|
October 12, 2012
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
Domenico Angelucci, Nicola Tinari, Antonino Grassadonia, et al.
The Journal of Pathology
|
November 29, 2014
Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer
Rachel Zoe Carter, Kelli Cristina Micocci, Anthony Natoli, et al.
Oncotarget
|
March 20, 2016
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
Giuseppe Bronte, Tindara Franchina, Massimiliano Alù, et al.
Page
of 119
Search research articles
Search
Showing results (961-970 of 1,181) with videos related to
Sort By:
Page
of 119
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
The landscape of cancer rewired GPCR signaling axes
Chakit Arora, Marin Matic, Pierluigi DiChiaro, et al.
Plos One
|
February 25, 2022
Sample-to-answer, extraction-free, real-time RT-LAMP test for SARS-CoV-2 in nasopharyngeal, nasal, and saliva samples: Implications and use for surveillance testing
Kathryn A Kundrod, Mary E Natoli, Megan M Chang, et al.
Molecular Vision
|
March 13, 2018
Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment
Riccardo Natoli, Nilisha Fernando, Tess Dahlenburg, et al.
Journal of Clinical Medicine
|
April 23, 2022
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients
Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 7, 2012
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis
Enza Piccolo, Nicola Tinari, Daniela Semeraro, et al.
Plos One
|
January 10, 2024
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
Chiara Ronchini, Chiara Caprioli, Gianleo Tunzi, et al.
Oncotarget
|
September 15, 2017
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial
Luca Moscetti, Maria Agnese Fabbri, Clara Natoli, et al.
Journal of Cancer Research and Clinical Oncology
|
October 12, 2012
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
Domenico Angelucci, Nicola Tinari, Antonino Grassadonia, et al.
The Journal of Pathology
|
November 29, 2014
Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer
Rachel Zoe Carter, Kelli Cristina Micocci, Anthony Natoli, et al.
Oncotarget
|
March 20, 2016
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
Giuseppe Bronte, Tindara Franchina, Massimiliano Alù, et al.
Page
of 119